FDA Quarterly Activities Report
Author : United States. Food and Drug Administration. Program Information and Analysis Group
Publisher :
Page : 88 pages
File Size : 26,19 MB
Release : 1975
Category :
ISBN :
Author : United States. Food and Drug Administration. Program Information and Analysis Group
Publisher :
Page : 88 pages
File Size : 26,19 MB
Release : 1975
Category :
ISBN :
Author : United States. Food and Drug Administration
Publisher :
Page : 88 pages
File Size : 33,47 MB
Release :
Category : Drugs
ISBN :
Author : United States. Food and Drug Administration. Program Information and Analysis Group
Publisher :
Page : 104 pages
File Size : 11,82 MB
Release : 1995
Category : Biologicals
ISBN :
Author : United States. Food and Drug Administration. Program Information and Analysis Group
Publisher :
Page : 202 pages
File Size : 24,2 MB
Release :
Category : Food adulteration and inspection
ISBN :
Author : United States. Food and Drug Administration
Publisher :
Page : 338 pages
File Size : 23,47 MB
Release : 1970
Category : Biologicals
ISBN :
Author : United States. Food and Drug Administration. Medical Library
Publisher :
Page : 176 pages
File Size : 46,91 MB
Release : 1998
Category : Medical literature
ISBN :
Author :
Publisher :
Page : 264 pages
File Size : 32,76 MB
Release : 1991-06
Category : Government publications
ISBN :
Author : Lucas Richert
Publisher : Lexington Books
Page : 233 pages
File Size : 17,14 MB
Release : 2014-05-16
Category : History
ISBN : 0739182595
In the last quarter of the 20th century, politicians in Washington, as well as interest groups, regulatory policy makers, and drug industry leaders were forced to confront the hot-button issue of pharmaceutical regulation. The struggle always centered on product innovation, consumer protection, and choice in the free market. As the American economy stuttered in the late 1970s, the stakes were extremely high for the powerful drug industry and the American public. At the center of this drama was the Food and Drug Administration, which was censured from both the left and right of the political spectrum for being too strict and too lenient in the application of its regulatory powers. Lucas Richert explores the FDA, drugs, and politics in the context of the watershed Reagan era, a period when the rhetoric of limited government, reduced regulation, and enhanced cooperation between businesses and U.S. regulatory agencies was on the ascent. As he investigates the controversies surrounding Laetrile, Reye’s Syndrome, Oraflex, patient package inserts, diet pills, and HIV/AIDS drugs, Richert argues that the practical application of conservative economic principles to the American drug industry was A Prescription for Scandal.
Author :
Publisher :
Page : 1090 pages
File Size : 47,52 MB
Release : 1980
Category : Government publications
ISBN :
Author :
Publisher :
Page : pages
File Size : 17,17 MB
Release : 1975
Category :
ISBN :